{"id":348337,"date":"2020-12-29T07:15:49","date_gmt":"2020-12-29T10:15:49","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=348337"},"modified":"2020-12-29T07:15:49","modified_gmt":"2020-12-29T10:15:49","slug":"china-otra-vacuna-lista-para-prueba-en-humanos","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/","title":{"rendered":"China, otra vacuna lista para prueba en humanos"},"content":{"rendered":"<p style=\"text-align: justify;\"><em><strong>Pek\u00edn.-<\/strong><\/em>Otra potencial vacuna china contra el Covid-19 basada en un vector adenoviral est\u00e1 lista para ser probada en humanos, tanto en el pa\u00eds como en el extranjero.<!--more--><\/p>\n<p style=\"text-align: justify;\">Lo anunciaron hoy investigadores de la Universidad de Tsinghua, la Universidad M\u00e9dica de Tianjin y Walvax Biotechnology Co. Ltd. en Kunming, que comenzaron a desarrollar la vacuna potencial desde el brote de la epidemia.<\/p>\n<p style=\"text-align: justify;\">\u00a0En comparaci\u00f3n con otras potenciales vacunas, esta se produjo utilizando sangre de chimpanc\u00e9.<\/p>\n<p style=\"text-align: justify;\">\u00a0Visto que generalmente no existe un anticuerpo neutralizante contra el adenovirus del chimpanc\u00e9 prealmacenados en el cuerpo humano -explic\u00f3 el investigador Zhang Linqi de la Universidad de Tsinghua, jefe del proyecto de desarrollo- la vacuna basada en este vector adenoviral tiene varias ventajas, como el n\u00famero limitado de posibles reacciones adversas, alta capacidad de producci\u00f3n y alto nivel de inmunizaci\u00f3n despu\u00e9s de la administraci\u00f3n. Los desarrolladores de la posible vacuna completaron las pruebas en animales y comenzaron a postularse para comenzar las pruebas en humanos tanto en China como en el extranjero.<\/p>\n<p style=\"text-align: justify;\">\u00abNo ha habido efectos secundarios graves en los animales\u00bb, coment\u00f3 Zhang, seg\u00fan el cual los resultados de la investigaci\u00f3n precl\u00ednica destacan la seguridad de esta vacuna y sugieren su alto potencial para futuras pruebas cl\u00ednicas.<\/p>\n<p style=\"text-align: justify;\">\u00a0La fase 3 de experimentaci\u00f3n cl\u00ednica, observ\u00f3 el investigador, \u00absirve para verificar la eficacia de la potencial vacuna y se llevar\u00e1 a cabo en varias \u00e1reas afectadas por la pandemia en el exterior\u00bb.<\/p>\n<p style=\"text-align: justify;\">\u00a0\u00abAl igual que con otras vacunas chinas contra el Covid-19, debemos hacer frente al insuficiente n\u00famero de pacientes positivos en China para participar en estudios de fase 3\u00bb.<\/p>\n<p style=\"text-align: justify;\">El pasado domingo se instal\u00f3 en el distrito de Daxing de Pek\u00edn una planta para la producci\u00f3n industrial de esta vacuna basada en un vector adenoviral de los chimpanc\u00e9s. Si la vacuna resulta eficaz en los ensayos cl\u00ednicos, se producir\u00e1 en masa dentro de la instalaci\u00f3n.<\/p>\n<p style=\"text-align: justify;\">Las instalaciones de producci\u00f3n est\u00e1n actualmente en construcci\u00f3n y se espera que la vacuna llegue al mercado a mediados de 2021. Seg\u00fan una nota difundida por Walvax, la capacidad de producci\u00f3n anual de esta vacuna contra el Covid-19 superar\u00e1 las 200 millones de dosis.<\/p>\n<p style=\"text-align: justify;\">Actualmente, cinco vacunas chinas han entrado en ensayos cl\u00ednicos de fase 3, incluido uno basado en un vector adenoviral desarrollado por la Academia de Ciencias Militares y CanSino Biologics Inc., revel\u00f3 un funcionario de la Comisi\u00f3n Nacional de Salud a principios de diciembre. Ansa.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pek\u00edn.-Otra potencial vacuna china contra el Covid-19 basada en un vector adenoviral est\u00e1 lista para ser probada en humanos, tanto en el pa\u00eds como en el extranjero.<\/p>\n","protected":false},"author":11,"featured_media":348338,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5],"tags":[2800,4622,4623,1060],"class_list":["post-348337","post","type-post","status-publish","format-standard","has-post-thumbnail","category-internacionales","tag-china","tag-nueva-vacuna","tag-prueba","tag-salud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>China, otra vacuna lista para prueba en humanos - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China, otra vacuna lista para prueba en humanos - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"Pek\u00edn.-Otra potencial vacuna china contra el Covid-19 basada en un vector adenoviral est\u00e1 lista para ser probada en humanos, tanto en el pa\u00eds como en el extranjero.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-29T10:15:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2020\/12\/China-Vacuna.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"653\" \/>\n\t<meta property=\"og:image:height\" content=\"368\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"vrios\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"vrios\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/\"},\"author\":{\"name\":\"vrios\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/fa3668852e893cb0423795330f919039\"},\"headline\":\"China, otra vacuna lista para prueba en humanos\",\"datePublished\":\"2020-12-29T10:15:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/\"},\"wordCount\":429,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/China-Vacuna.jpg\",\"keywords\":[\"China\",\"Nueva Vacuna\",\"Prueba\",\"Salud\"],\"articleSection\":[\"Internacionales\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/\",\"name\":\"China, otra vacuna lista para prueba en humanos - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/China-Vacuna.jpg\",\"datePublished\":\"2020-12-29T10:15:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/China-Vacuna.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/China-Vacuna.jpg\",\"width\":653,\"height\":368,\"caption\":\"Marca\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2020\\\/12\\\/29\\\/china-otra-vacuna-lista-para-prueba-en-humanos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China, otra vacuna lista para prueba en humanos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/LOGO-ip-mobile.png\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/LOGO-ip-mobile.png\",\"width\":140,\"height\":44,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/fa3668852e893cb0423795330f919039\",\"name\":\"vrios\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/vrios\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"China, otra vacuna lista para prueba en humanos - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/","og_locale":"es_ES","og_type":"article","og_title":"China, otra vacuna lista para prueba en humanos - .::Agencia IP::.","og_description":"Pek\u00edn.-Otra potencial vacuna china contra el Covid-19 basada en un vector adenoviral est\u00e1 lista para ser probada en humanos, tanto en el pa\u00eds como en el extranjero.","og_url":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2020-12-29T10:15:49+00:00","og_image":[{"width":653,"height":368,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2020\/12\/China-Vacuna.jpg","type":"image\/jpeg"}],"author":"vrios","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"vrios","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/"},"author":{"name":"vrios","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/fa3668852e893cb0423795330f919039"},"headline":"China, otra vacuna lista para prueba en humanos","datePublished":"2020-12-29T10:15:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/"},"wordCount":429,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2020\/12\/China-Vacuna.jpg","keywords":["China","Nueva Vacuna","Prueba","Salud"],"articleSection":["Internacionales"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/","url":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/","name":"China, otra vacuna lista para prueba en humanos - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2020\/12\/China-Vacuna.jpg","datePublished":"2020-12-29T10:15:49+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2020\/12\/China-Vacuna.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2020\/12\/China-Vacuna.jpg","width":653,"height":368,"caption":"Marca"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2020\/12\/29\/china-otra-vacuna-lista-para-prueba-en-humanos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"China, otra vacuna lista para prueba en humanos"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2019\/03\/LOGO-ip-mobile.png","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2019\/03\/LOGO-ip-mobile.png","width":140,"height":44,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/fa3668852e893cb0423795330f919039","name":"vrios","url":"https:\/\/www.ip.gov.py\/ip\/author\/vrios\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/348337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=348337"}],"version-history":[{"count":0,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/348337\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/348338"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=348337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=348337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=348337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}